Keith Delong
Family · Columbus, OHNPI 1629406863
Payments from drug & device makers
Across 187 payments — averaging $46.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$6K
- Viiv Healthcare Company$1K
- Janssen Products, LP$483
- Merck$238
- Johnson & Johnson$147
- Lilly USA, LLC$135
- plus $733 from 17 others
What the payments were for
- Consulting fees$2,31026%
- Travel & lodging$1,66419%
- Food & beverage$4,59853%
- Education$1492%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 75 | $5,781 |
| Viiv Healthcare Company | 42 | $1,205 |
| Janssen Products, LP | 5 | $483 |
| Merck | 13 | $238 |
| Johnson & Johnson(2 entities) | 9 | $147 |
| Lilly USA, LLC | 7 | $135 |
| AbbVie | 7 | $128 |
| Exact Sciences | 4 | $78 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Pfizer | 3 | $56 |
| EMD Serono, Inc. | 2 | $48 |
| Napo Pharmaceuticals Inc | 2 | $45 |
| Novo Nordisk | 3 | $44 |
| Verity Pharmaceuticals Inc. | 1 | $37 |
| Organon | 1 | $35 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Vertex | 1 | $21 |
| Coopersurgical, Inc. | 1 | $18 |
| Theratechnologies Inc. | 1 | $17 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| AstraZeneca | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,722 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 96 | $369,748 |
| DescovyEmtricitabine/Tenofov Alafenam | 51 | $106,138 |
| DovatoDolutegravir Sodium/Lamivudine | 30 | $86,291 |
| GenvoyaElviteg/Cob/Emtri/Tenof Alafen | 13 | $52,886 |
| OdefseyEmtricitab/Rilpiviri/Tenof Ala | 13 | $45,000 |
| TivicayDolutegravir Sodium | 17 | $38,122 |
| JardianceEmpagliflozin | 29 | $21,107 |
| OzempicSemaglutide | 22 | $20,033 |
| TrulicityDulaglutide | 11 | $10,576 |
| Testosterone | 11 | $9,114 |
| EliquisApixaban | 12 | $6,848 |
| FarxigaDapagliflozin Propanediol | 11 | $6,024 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $1,256 |
| Emtricitabine-Tenofovir DisopEmtricitabine/Tenofovir (Tdf) | 19 | $1,186 |
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 14 | $831 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GileadBiktarvy, Descovy, Genvoya | $5,781 | $528,772160 claims |
| Viiv Healthcare CompanyDovato, Tivicay | $1,205 | $124,41347 claims |
| Novo NordiskOzempic | $44 | $20,03322 claims |
| Lilly USA, LLCTrulicity | $135 | $10,57611 claims |
| PfizerEliquis | $56 | $6,84812 claims |
| AstraZenecaFarxiga | $17 | $6,02411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.
Other family in Columbus
- Christina GastColumbus$66K
- Beth LoessinColumbus$34K
- Mary HurleyColumbus$15K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.